AMPH vs. AVGO
AMPH (Amphastar Pharmaceuticals, Inc.) and AVGO (Broadcom Inc.) are both stocks. AMPH operates in Drug Manufacturers - Specialty & Generic (Healthcare), while AVGO operates in Semiconductors (Technology). Over the past 10 years, AMPH returned 1.39%/yr vs 43.87%/yr for AVGO. At a 0.20 correlation, their price movements are largely independent.
Performance
AMPH vs. AVGO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AMPH achieves a -32.34% return, which is significantly lower than AVGO's 38.76% return. Over the past 10 years, AMPH has underperformed AVGO with an annualized return of 1.39%, while AVGO has yielded a comparatively higher 43.87% annualized return.
AMPH
- 1D
- -1.79%
- 1M
- -20.32%
- YTD
- -32.34%
- 6M
- -34.30%
- 1Y
- -30.33%
- 3Y*
- -27.06%
- 5Y*
- -0.72%
- 10Y*
- 1.39%
AVGO
- 1D
- -0.49%
- 1M
- 15.06%
- YTD
- 38.76%
- 6M
- 26.42%
- 1Y
- 88.09%
- 3Y*
- 83.13%
- 5Y*
- 61.98%
- 10Y*
- 43.87%
AMPH vs. AVGO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals, Inc. | -32.34% | -27.88% | -39.97% | 120.74% | 20.31% | 15.81% | 4.25% | -3.07% | 3.43% | 4.45% |
AVGO Broadcom Inc. | 38.76% | 50.63% | 110.49% | 104.18% | -13.27% | 56.48% | 44.88% | 29.05% | 2.18% | 48.19% |
Correlation
The correlation between AMPH and AVGO is 0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.00 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Jun 26, 2014 | 0.20 |
The correlation between AMPH and AVGO shifts across timeframes, from 0.00 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.
Fundamentals
AMPH:
$841.82M
AVGO:
$2.34T
AMPH:
$1.67
AVGO:
$5.12
AMPH:
10.83
AVGO:
93.63
AMPH:
0.57
AVGO:
1.16
AMPH:
1.19
AVGO:
34.24
AMPH:
1.09
AVGO:
29.33
AMPH:
$720.53M
AVGO:
$68.28B
AMPH:
$341.13M
AVGO:
$46.31B
AMPH:
$155.96M
AVGO:
$36.65B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMPH vs. AVGO — Risk / Return Rank
AMPH
AVGO
AMPH vs. AVGO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AMPH | AVGO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.64 | ||
| Sortino ratioReturn per unit of downside risk | -3.25 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 1.34 | -0.42 |
| Calmar ratioReturn relative to maximum drawdown | -0.67 | 3.09 | -3.76 |
| Martin ratioReturn relative to average drawdown | -1.39 | 7.42 | -8.81 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AMPH | AVGO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.57 | 2.07 | -2.64 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.02 | 1.46 | -1.47 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.03 | 1.12 | -1.09 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.15 | 1.14 | -0.99 |
Drawdowns
AMPH vs. AVGO - Drawdown Comparison
The maximum AMPH drawdown since its inception was -74.05%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for AMPH and AVGO.
Loading charts...
Drawdown Indicators
| AMPH | AVGO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.05% | -48.30% | -25.75% |
Max Drawdown (1Y)Largest decline over 1 year | -45.25% | -28.67% | -16.58% |
Max Drawdown (3Y)Largest decline over 3 years | -74.05% | -41.15% | -32.90% |
Max Drawdown (5Y)Largest decline over 5 years | -74.05% | -41.15% | -32.90% |
Max Drawdown (10Y)Largest decline over 10 years | -74.05% | -48.30% | -25.75% |
Current DrawdownCurrent decline from peak | -72.12% | -0.49% | -71.63% |
Average DrawdownAverage peak-to-trough decline | -23.98% | -7.97% | -16.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.90% | 11.91% | +9.99% |
Volatility
AMPH vs. AVGO - Volatility Comparison
Amphastar Pharmaceuticals, Inc. (AMPH) has a higher volatility of 26.71% compared to Broadcom Inc. (AVGO) at 11.91%. This indicates that AMPH's price experiences larger fluctuations and is considered to be riskier than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AMPH | AVGO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.71% | 11.91% | +14.80% |
Volatility (6M)Calculated over the trailing 6-month period | 45.74% | 30.70% | +15.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 53.42% | 42.95% | +10.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.99% | 42.78% | +2.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 42.65% | 39.18% | +3.47% |
Dividends
AMPH vs. AVGO - Dividend Comparison
AMPH has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.52%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AVGO Broadcom Inc. | 0.52% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
Financials
AMPH vs. AVGO - Financials Comparison
This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMPH vs. AVGO - Profitability Comparison
AMPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported a gross profit of 70.32M and revenue of 171.17M. Therefore, the gross margin over that period was 41.1%.
AVGO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a gross profit of 13.16B and revenue of 19.31B. Therefore, the gross margin over that period was 68.1%.
AMPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported an operating income of 13.63M and revenue of 171.17M, resulting in an operating margin of 8.0%.
AVGO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported an operating income of 8.56B and revenue of 19.31B, resulting in an operating margin of 44.3%.
AMPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Amphastar Pharmaceuticals, Inc. reported a net income of 6.42M and revenue of 171.17M, resulting in a net margin of 3.8%.
AVGO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a net income of 7.35B and revenue of 19.31B, resulting in a net margin of 38.1%.
Frequently Asked Questions
AMPH and AVGO have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AMPH has higher volatility (26.71%) compared to AVGO (11.91%). In terms of maximum drawdown, AMPH dropped -74.05% vs AVGO's -48.30%.
AVGO currently has the higher Sharpe Ratio (2.07 vs -0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AMPH and AVGO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer